CA2718245C - Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation. - Google Patents

Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation. Download PDF

Info

Publication number
CA2718245C
CA2718245C CA2718245A CA2718245A CA2718245C CA 2718245 C CA2718245 C CA 2718245C CA 2718245 A CA2718245 A CA 2718245A CA 2718245 A CA2718245 A CA 2718245A CA 2718245 C CA2718245 C CA 2718245C
Authority
CA
Canada
Prior art keywords
ebv
polypeptide
zebra
amino acid
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2718245A
Other languages
English (en)
French (fr)
Other versions
CA2718245A1 (en
Inventor
Emmanuel Drouet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Joseph Fourier University
Original Assignee
Joseph Fourier University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joseph Fourier University filed Critical Joseph Fourier University
Publication of CA2718245A1 publication Critical patent/CA2718245A1/en
Application granted granted Critical
Publication of CA2718245C publication Critical patent/CA2718245C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
    • G01N2333/05—Epstein-Barr virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA2718245A 2008-03-10 2009-03-10 Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation. Expired - Fee Related CA2718245C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08290224.8 2008-03-10
EP08290224A EP2101177A1 (en) 2008-03-10 2008-03-10 Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (EBV) reactivation
PCT/EP2009/052798 WO2009112497A1 (en) 2008-03-10 2009-03-10 Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation

Publications (2)

Publication Number Publication Date
CA2718245A1 CA2718245A1 (en) 2009-09-17
CA2718245C true CA2718245C (en) 2017-04-18

Family

ID=39595705

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2718245A Expired - Fee Related CA2718245C (en) 2008-03-10 2009-03-10 Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation.

Country Status (9)

Country Link
US (1) US20110076671A1 (enExample)
EP (2) EP2101177A1 (enExample)
JP (1) JP5592277B2 (enExample)
CN (1) CN102016586B (enExample)
AT (1) ATE530913T1 (enExample)
CA (1) CA2718245C (enExample)
ES (1) ES2375095T3 (enExample)
MY (1) MY156432A (enExample)
WO (1) WO2009112497A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2983482B1 (fr) * 2011-12-05 2017-10-20 Univ Joseph Fourier Utilisation d'au moins un biomarqueur pour le pronostic ou le diagnostic in vitro d'episodes lymphoproliferatifs associes au virus d'epstein-barr (ebv)
WO2014025254A1 (en) 2012-08-10 2014-02-13 Stichting Vu-Vumc Ebv markers and systemic lupus erythematosus
CN109679975B (zh) * 2019-01-23 2020-12-08 济宁医学院 一种改造bzlf1和改造lmp1的融合基因及其应用
CN113061165B (zh) * 2020-01-02 2026-04-21 厦门大学 EB病毒BNLF2b基因编码多肽及其检测用途
CN111826412A (zh) * 2020-06-02 2020-10-27 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 一种高通量检测eb病毒感染效率/抗体阻断eb病毒感染效率的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994006470A1 (en) * 1992-09-15 1994-03-31 Johnson & Johnson Immunoreactive peptides from epstein-barr virus
FR2728904B1 (fr) * 1995-01-04 1997-03-14 Pasteur Institut Reactif peptidique permettant de detecter une infection primaire a virus d'epstein-barr par recherche des anticorps correspondants, et procede d'utilisation de ce reactif
ATE211172T1 (de) * 1995-06-06 2002-01-15 Organon Teknika Bv Epstein-barr viruspeptide, und antikörper gegen diese peptide
JPH11511853A (ja) * 1996-03-29 1999-10-12 オルソ ダイアグノスティック システムズ インク エプスタイン・バーウイルス関連疾患の診断法
FR2791142B1 (fr) * 1999-03-17 2001-06-22 Univ Grenoble 1 Utilisation de la brefeldine a pour augmenter l'effet de presentation d'antigenes exogenes par les cpa
US20070196389A1 (en) * 2005-11-18 2007-08-23 The Ohio State University Research Foundation Viral gene products and methods for vaccination to prevent viral associated diseases

Also Published As

Publication number Publication date
EP2269069A1 (en) 2011-01-05
CA2718245A1 (en) 2009-09-17
JP2011513759A (ja) 2011-04-28
JP5592277B2 (ja) 2014-09-17
WO2009112497A1 (en) 2009-09-17
CN102016586B (zh) 2015-01-21
US20110076671A1 (en) 2011-03-31
CN102016586A (zh) 2011-04-13
EP2101177A1 (en) 2009-09-16
MY156432A (en) 2016-02-26
ES2375095T3 (es) 2012-02-24
ATE530913T1 (de) 2011-11-15
EP2269069B1 (en) 2011-10-26

Similar Documents

Publication Publication Date Title
OBEL et al. Serological and clinical findings in patients with serological evidence of reactivated Epstein‐Barr virus infection
JP4612071B2 (ja) エプスタイン−バールウイルスペプチド及び該ペプチドに対する抗体
EP2269069B1 (en) Use of synthetic peptide derived from zebra protein for the in vivo diagnosis of the epstein-barr virus (ebv) reactivation
Yao et al. Salivary and serum IgA antibodies to the epstein—barr virus glycoprotein gp340: incidence and potential for virus neutralization
JP3547493B2 (ja) Ｅｂｖに対する抗体の検出用診断試薬
Wittekindt et al. Detection of human serum antibodies against type-specifically reactive peptides from the N-terminus of glycoprotein B of herpes simplex virus type 1 and type 2 by surface plasmon resonance
AU735981B2 (en) Peptide reagent for the detection of human cytomegalovirus (CMV)
Paramita et al. Native early antigen of Epstein–Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma
EP0842430B1 (en) Herpes simplex virus diagnostics
Färber et al. Serological diagnosis of infectious mononucleosis using three anti-Epstein-Barr virus recombinant ELISAs
JP3557215B2 (ja) 対応の抗体を検出することによりエプスタイン・バールウイルス原発性感染症を検査し得るペプチド試薬及びこのペプチド試薬を用いる方法
US20140106381A1 (en) Method for the diagnosis of rheumatoid arthritis
US6818219B1 (en) Reagent for detecting and monitoring viral infections
JP7517659B2 (ja) ＥＢウイルスＢＮＬＦ２ｂ遺伝子によりコードされるポリペプチド及び検出におけるその使用
CN100467483C (zh) 衍生自非洲淋巴瘤病毒VCA-p18衣壳抗原的肽及其用途
CA2259967C (en) Peptide reagent for the detection of human cytomegalovirus (cmv)
Tselis et al. Epstein-Barr virus disease-serologic and virologic diagnosis
CN106831962A (zh) 用于检测人类疱疹病毒8型感染的多肽及试剂盒

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140221

MKLA Lapsed

Effective date: 20190311